Adeno-Associated Virus Serotype 6 Capsid Tyrosine-to-Phenylalanine Mutations Improve Gene Transfer to Skeletal Muscle
Year: 2010
Type: article
Abstract: Adeno-associated viral (AAV) vectors are the most efficient in vivo gene transfer tools for gene therapy applications. Efforts have been made to translate encouraging results in small animal models to human patients. However, the need for large quantities of vector for clinical application remains a great challenge. Developing novel AAV vectors with enhanced infectivity may reduce the high vector dose requirement for many applications such as gene therapy for muscular dystrophy. Selective mutation of AAV capsid surface-exposed tyrosine (Y) is a novel strategy to improve transduction efficiency. AAV6 has been considered one of the most robust muscle gene delivery vehicles. Here, we hypothesize that AAV6 transduction efficiency can be further enhanced by mutating surface Y to phenylalanine (F). We found that mutants AAV6-Y445F and AAV6-Y731F, especially the former, achieved more efficient gene transfer than the original AAV6 after intramuscular administration to mice. Expression of both firefly luciferase and alkaline phosphatase reporter genes increased up to 8-fold and DNA copy numbers in muscle increased up to 6-fold. Our results suggest that tyrosine-mutant AAV6 vectors may represent powerful tools for testing muscle gene therapy in animal models and potentially in humans.
Source: Human Gene Therapy
DOI: 10.1089/hum.2010.003
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: green
Funders: American Cancer Society, Fanconi Anemia Research Fund, National Institutes of Health, National Heart, Lung, and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institute of Biomedical Imaging and Bioengineering
Awards: Human Parvovirus B19 Vectors: Mechanism of Transduction, Recombinant AAV for Correction of Genetic Abnormalities, Parvovirus Vectors for Human Gene Therapy, AAV Vectors for Heart and Muscle Gene Therapy, G5162730615, Myostatin Inhibition in DMD Dogs by Gene Transfer, Dual AAV Vectors for Duchenne Muscular Dystrophy Therapy, G8240899521
OpenAlex ID: W2023319852
